Clinical Trials Browser

Phase NA × Risk Reduction Behavior × Dermatologic × Clear all

NCT03315286 2019-12-18

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Phase NA Completed

111 enrolled 13 charts

Skin Neoplasms, Health Behavior, Risk Reduction Behavior, Keratosis, Actinic